Add Yahoo as a preferred source to see more of our stories on Google. Men interviewed by CBC/Radio Canada during a six-month investigation of the hair loss drug finasteride say it caused sexual, ...

Post Finasteride Syndrome: What is It? If you’re dealing with male pattern baldness, there’s a good chance you’ve heard of or use finasteride. You also may have heard rumors about finasteride insomnia ...

If you’re thinking of switching from finasteride to dutasteride for hair loss, there are some critical things to know. Only two medications are approved by the Food and Drug Administration (FDA) ...

This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255). Millions of men undergoing hair ...

A recent FDA alert warned of lasting side effects from the topical form of finasteride, a popular hair loss medication. The FDA has received 32 reports of adverse effects, including erectile ...

The FDA issued a public alert on Tuesday concerning generic versions of a widely-used hair loss drug that is frequently distributed by popular telehealth brands like Hims and Keeps. The agency cited ...

Minoxidil is widely considered the gold-standard hair loss treatment says Dr. Kimberly Salkey, MD, Associate Professor and ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Noticing a receding hairline? You’re not alone — and thanks to ...

A whopping 85% of men experience significantly thinning hair by age 50, and two-thirds experience noticeable hair loss by age ...

The Food and Drug Administration (FDA) added new warnings on Wednesday to finasteride, the drug used to treat male pattern baldness and enlarged prostate, citing sexual side effects that continue to ...

The most common type of hair loss is male-pattern baldness, where sufferers often experience a receding hairline followed by thinning of hair on the crown and temples. Article continues below ...